3SBio reels in heavyweight cornerstones for $712m HK IPO
Chinese biotech firm 3SBio has bagged $150m from some heavyweight cornerstone investors including GIC and BlackRock ahead of launching its HK$5.51bn ($712m) Hong Kong IPO, putting the company’s second flotation on a very strong footing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: